These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6590188)

  • 61. Toxicity of alkaloids to certain bacteria. II. Berberine, physostigmine, and sanguinarine.
    JOHNSON CC; JOHNSON G; POE CF
    Acta Pharmacol Toxicol (Copenh); 1952; 8(1):71-8. PubMed ID: 14933116
    [No Abstract]   [Full Text] [Related]  

  • 62. White patch of maxillary vestibule. Sanguinarine-associated leukoplakia.
    Damm DD; Fantasia JE
    Gen Dent; 2002; 50(5):466, 468. PubMed ID: 12448901
    [No Abstract]   [Full Text] [Related]  

  • 63. [Recent data on the pharmacology of chelidonine and sanguinarine].
    KELENTEY B
    Kiserl Orvostud; 1959 Dec; 11():591-8. PubMed ID: 13853338
    [No Abstract]   [Full Text] [Related]  

  • 64. [A disorder in the energy-conversion processes in the liver mitochondria of rats under the action of sanguinarin and AFMA].
    Beliaeva TN; Faddeeva MD
    Tsitologiia; 1995; 37(3):237-48. PubMed ID: 8553463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin cytoskeleton of macrophages].
    Mozhenok TP; Beliaeva TN; Leont'eva EA; Faddeeva MD
    Tsitologiia; 2005; 47(10):860-5. PubMed ID: 16711384
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity.
    Huh J; Liepins A; Zielonka J; Andrekopoulos C; Kalyanaraman B; Sorokin A
    Cancer Res; 2006 Apr; 66(7):3726-36. PubMed ID: 16585199
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells.
    Ahmad N; Gupta S; Husain MM; Heiskanen KM; Mukhtar H
    Clin Cancer Res; 2000 Apr; 6(4):1524-8. PubMed ID: 10778985
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: implications for prevention of skin cancer.
    Ahsan H; Reagan-Shaw S; Eggert DM; Tan TC; Afaq F; Mukhtar H; Ahmad N
    Photochem Photobiol; 2007; 83(4):986-93. PubMed ID: 17645675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine, in rats and guinea pigs.
    Tandon S; Das M; Khanna SK
    Drug Metab Dispos; 1993; 21(1):194-7. PubMed ID: 8095219
    [No Abstract]   [Full Text] [Related]  

  • 70. Argemone oil, sanguinarine, and epidemic-dropsy glaucoma.
    HAKIM SA
    Br J Ophthalmol; 1954 Apr; 38(4):193-216. PubMed ID: 13149763
    [No Abstract]   [Full Text] [Related]  

  • 71. Protective effect of bioantioxidants on argemone oil/sanguinarine alkaloid induced genotoxicity in mice.
    Ansari KM; Dhawan A; Khanna SK; Das M
    Cancer Lett; 2006 Nov; 244(1):109-18. PubMed ID: 16458423
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sanguinarine blocks cytokinesis in bacteria by inhibiting FtsZ assembly and bundling.
    Beuria TK; Santra MK; Panda D
    Biochemistry; 2005 Dec; 44(50):16584-93. PubMed ID: 16342949
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular aspects on the interaction of sanguinarine with B-form, Z-form and HL-form DNA structures.
    Maiti M
    Indian J Biochem Biophys; 2001; 38(1-2):20-6. PubMed ID: 11563326
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Experimental transmission of sanguinarine in milk: detection of a metabolic product.
    HAKIM SA; MIJOVIC V; WALKER J
    Nature; 1961 Jan; 189():201-4. PubMed ID: 13710638
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of quaternary benzo[c]phenanthridine alkaloids sanguinarine, chelerythrine and fagaronine on some mammalian cells.
    Vavrecková C; Ulrichová J; Hajdúch M; Grambal F; Weigl E; Simánek V
    Acta Univ Palacki Olomuc Fac Med; 1994; 138():7-10. PubMed ID: 8714083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine.
    Kemény-Beke A; Aradi J; Damjanovich J; Beck Z; Facskó A; Berta A; Bodnár A
    Cancer Lett; 2006 Jun; 237(1):67-75. PubMed ID: 16019128
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice.
    Ansari KM; Dhawan A; Khanna SK; Das M
    Food Chem Toxicol; 2005 Jan; 43(1):147-53. PubMed ID: 15582207
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Questions on use of sanguinaria.
    Keogh TP
    J Am Dent Assoc; 1987 Nov; 115(5):674. PubMed ID: 3479488
    [No Abstract]   [Full Text] [Related]  

  • 79. [On the pharmacology of chelidonine and sanguinarine].
    KELENTEY B
    Arzneimittelforschung; 1960 Feb; 10():135-7. PubMed ID: 13853337
    [No Abstract]   [Full Text] [Related]  

  • 80. Laboratory procedures developed to assess possible antiplaque compounds.
    Melger H; Eilberg RG
    Quintessence Int Dent Dig; 1980 Dec; 11(12):81-4. PubMed ID: 6454160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.